Thymopoietin

Also known as: TP, Thymopoietin II

ImmunePRECLINICAL

Clinical Status

Preclinical — research compound for immune modulation.

Mechanism of Action

A 49-amino-acid polypeptide from thymic epithelium that induces T-cell differentiation markers, modulates neuromuscular transmission, and supports the maturation of bone marrow progenitors into functional T lymphocytes.

Dosing Defaults

Dose

1-5 mg

Frequency

2-3x weekly

Administration

Subcutaneous injection

Timing

Morning

Food

with or without

Duration

4-8 weeks

Dose range: 1-10 mg per dose

Morning administration supports immune activation during waking hours.

Side Effects

•Injection site reactions
•Fatigue
•Mild muscle weakness
•Headache

Contraindications & Warnings

⚠Myasthenia gravis

•Not medical advice
•May affect neuromuscular function

Compare

Compare Thymopoietin with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Thymopoietin dose.

Open Calculator

Related Immune Peptides

LL-37

PHASE 1

Immune

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

KPV

PRECLINICAL

Immune

Anti-inflammatory peptide fragment. Does NOT cause immunosuppression.

Thymosin Alpha-1

PHASE 3

Immune

Thymic peptide for immune modulation. Approved in 35+ countries.

VIP

PHASE 2

Immune

Immunomodulatory peptide used in mold illness (CIRS) protocols.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.